Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330496 | SCV004038819 | likely pathogenic | Niemann-Pick disease, type C | 2023-08-22 | criteria provided, single submitter | clinical testing | Variant summary: NPC2 c.3G>C (p.Met1Ile) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. The next downstream in frame initiation codon is at Met79. The variant was absent in 246888 control chromosomes. c.3G>C has been reported in the literature in individuals affected with Niemann-Pick Disease Type C (Zhang_2014). Additionally, disruptions of the start codon have been associated with pathogenicity in ClinVar and observed in multiple individuals with Niemann-Pick Diease (PMIDs: 19252935, 32138288). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 24915861). No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
Labcorp Genetics |
RCV000119339 | SCV004297123 | pathogenic | Niemann-Pick disease, type C2 | 2023-12-24 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the NPC2 mRNA. The next in-frame methionine is located at codon 79. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with Niemann-Pick disease type C (PMID: 19252935, 24915861). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 132902). This variant disrupts a region of the NPC2 protein in which other variant(s) (p.Cys47Phe) have been observed in individuals with NPC2-related conditions (PMID: 12955717, 15937921, 17470133). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Shanghain Institute for Pediatric Research | RCV000119339 | SCV000154198 | pathogenic | Niemann-Pick disease, type C2 | no assertion criteria provided | not provided | Converted during submission to Pathogenic. |